vs

Side-by-side financial comparison of Dayforce (DAY) and LivaNova PLC (LIVN). Click either name above to swap in a different company.

Dayforce is the larger business by last-quarter revenue ($481.6M vs $360.9M, roughly 1.3× LivaNova PLC). LivaNova PLC runs the higher net margin — 8.6% vs -40.9%, a 49.4% gap on every dollar of revenue. On growth, LivaNova PLC posted the faster year-over-year revenue change (12.1% vs 9.5%). Over the past eight quarters, LivaNova PLC's revenue compounded faster (10.6% CAGR vs 9.8%).

Dayforce, Inc., formerly Ceridian, is an American human resources software and services company.

LivaNova, plc is an American medical device manufacturer based in the UK. The company develops devices used for cardiac surgery and neuromodulation. The company was formed in 2015 by a $2.7B merger between Houston, Texas-based Cyberonics, Inc. and Milan, Italy-based Sorin S.p.a. The company trades on the NASDAQ stock exchange under the ticker symbol "LIVN".

DAY vs LIVN — Head-to-Head

Bigger by revenue
DAY
DAY
1.3× larger
DAY
$481.6M
$360.9M
LIVN
Growing faster (revenue YoY)
LIVN
LIVN
+2.7% gap
LIVN
12.1%
9.5%
DAY
Higher net margin
LIVN
LIVN
49.4% more per $
LIVN
8.6%
-40.9%
DAY
Faster 2-yr revenue CAGR
LIVN
LIVN
Annualised
LIVN
10.6%
9.8%
DAY

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
DAY
DAY
LIVN
LIVN
Revenue
$481.6M
$360.9M
Net Profit
$-196.8M
$30.9M
Gross Margin
65.2%
Operating Margin
6.3%
11.8%
Net Margin
-40.9%
8.6%
Revenue YoY
9.5%
12.1%
Net Profit YoY
-9940.0%
-44.7%
EPS (diluted)
$-1.23
$0.57

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DAY
DAY
LIVN
LIVN
Q4 25
$360.9M
Q3 25
$481.6M
$357.8M
Q2 25
$464.7M
$352.5M
Q1 25
$481.8M
$316.9M
Q4 24
$465.2M
$321.8M
Q3 24
$440.0M
$318.1M
Q2 24
$423.3M
$318.6M
Q1 24
$431.5M
$294.9M
Net Profit
DAY
DAY
LIVN
LIVN
Q4 25
$30.9M
Q3 25
$-196.8M
$26.8M
Q2 25
$21.3M
$27.2M
Q1 25
$14.9M
$-327.3M
Q4 24
$10.8M
$55.9M
Q3 24
$2.0M
$33.0M
Q2 24
$-1.8M
$16.3M
Q1 24
$7.1M
$-41.9M
Gross Margin
DAY
DAY
LIVN
LIVN
Q4 25
65.2%
Q3 25
68.4%
Q2 25
67.8%
Q1 25
69.7%
Q4 24
47.0%
68.2%
Q3 24
45.8%
70.8%
Q2 24
44.1%
68.7%
Q1 24
47.6%
70.3%
Operating Margin
DAY
DAY
LIVN
LIVN
Q4 25
11.8%
Q3 25
6.3%
15.1%
Q2 25
9.1%
15.4%
Q1 25
6.4%
15.3%
Q4 24
6.1%
11.5%
Q3 24
4.7%
11.2%
Q2 24
3.3%
12.6%
Q1 24
9.4%
5.5%
Net Margin
DAY
DAY
LIVN
LIVN
Q4 25
8.6%
Q3 25
-40.9%
7.5%
Q2 25
4.6%
7.7%
Q1 25
3.1%
-103.3%
Q4 24
2.3%
17.4%
Q3 24
0.5%
10.4%
Q2 24
-0.4%
5.1%
Q1 24
1.6%
-14.2%
EPS (diluted)
DAY
DAY
LIVN
LIVN
Q4 25
$0.57
Q3 25
$-1.23
$0.49
Q2 25
$0.13
$0.50
Q1 25
$0.09
$-6.01
Q4 24
$0.07
$1.04
Q3 24
$0.01
$0.60
Q2 24
$-0.01
$0.30
Q1 24
$0.04
$-0.78

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DAY
DAY
LIVN
LIVN
Cash + ST InvestmentsLiquidity on hand
$627.6M
$635.6M
Total DebtLower is stronger
$631.1M
$376.1M
Stockholders' EquityBook value
$2.7B
$1.2B
Total Assets
$8.7B
$2.6B
Debt / EquityLower = less leverage
0.23×
0.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DAY
DAY
LIVN
LIVN
Q4 25
$635.6M
Q3 25
$627.6M
$646.1M
Q2 25
$625.2M
$593.6M
Q1 25
$557.3M
$738.4M
Q4 24
$579.7M
$428.9M
Q3 24
$494.1M
$346.4M
Q2 24
$465.4M
$329.2M
Q1 24
$392.5M
$309.2M
Total Debt
DAY
DAY
LIVN
LIVN
Q4 25
$376.1M
Q3 25
$631.1M
$434.5M
Q2 25
$631.8M
$430.6M
Q1 25
$632.4M
$628.2M
Q4 24
$1.2B
$627.0M
Q3 24
$1.2B
$625.5M
Q2 24
$1.2B
$624.5M
Q1 24
$1.2B
$623.8M
Stockholders' Equity
DAY
DAY
LIVN
LIVN
Q4 25
$1.2B
Q3 25
$2.7B
$1.2B
Q2 25
$2.7B
$1.1B
Q1 25
$2.6B
$1.0B
Q4 24
$2.5B
$1.3B
Q3 24
$2.6B
$1.3B
Q2 24
$2.5B
$1.2B
Q1 24
$2.4B
$1.2B
Total Assets
DAY
DAY
LIVN
LIVN
Q4 25
$2.6B
Q3 25
$8.7B
$2.6B
Q2 25
$8.5B
$2.5B
Q1 25
$9.5B
$2.6B
Q4 24
$9.1B
$2.5B
Q3 24
$8.1B
$2.5B
Q2 24
$9.0B
$2.5B
Q1 24
$10.8B
$2.5B
Debt / Equity
DAY
DAY
LIVN
LIVN
Q4 25
0.31×
Q3 25
0.23×
0.38×
Q2 25
0.23×
0.38×
Q1 25
0.24×
0.61×
Q4 24
0.47×
0.47×
Q3 24
0.47×
0.48×
Q2 24
0.49×
0.50×
Q1 24
0.50×
0.51×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DAY
DAY
LIVN
LIVN
Operating Cash FlowLast quarter
$31.2M
$82.4M
Free Cash FlowOCF − Capex
$50.2M
FCF MarginFCF / Revenue
13.9%
Capex IntensityCapex / Revenue
8.9%
Cash ConversionOCF / Net Profit
2.67×
TTM Free Cash FlowTrailing 4 quarters
$173.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DAY
DAY
LIVN
LIVN
Q4 25
$82.4M
Q3 25
$31.2M
$85.1M
Q2 25
$112.7M
$62.9M
Q1 25
$49.6M
$24.0M
Q4 24
$81.0M
$78.7M
Q3 24
$91.8M
$51.0M
Q2 24
$99.2M
$43.4M
Q1 24
$9.1M
$10.0M
Free Cash Flow
DAY
DAY
LIVN
LIVN
Q4 25
$50.2M
Q3 25
$62.2M
Q2 25
$47.8M
Q1 25
$13.2M
Q4 24
$68.3M
Q3 24
$32.8M
Q2 24
$31.2M
Q1 24
$3.6M
FCF Margin
DAY
DAY
LIVN
LIVN
Q4 25
13.9%
Q3 25
17.4%
Q2 25
13.6%
Q1 25
4.2%
Q4 24
21.2%
Q3 24
10.3%
Q2 24
9.8%
Q1 24
1.2%
Capex Intensity
DAY
DAY
LIVN
LIVN
Q4 25
8.9%
Q3 25
6.4%
Q2 25
4.3%
Q1 25
3.4%
Q4 24
3.2%
Q3 24
5.7%
Q2 24
3.8%
Q1 24
2.2%
Cash Conversion
DAY
DAY
LIVN
LIVN
Q4 25
2.67×
Q3 25
3.18×
Q2 25
5.29×
2.32×
Q1 25
3.33×
Q4 24
7.50×
1.41×
Q3 24
45.90×
1.55×
Q2 24
2.65×
Q1 24
1.28×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DAY
DAY

Dayforce Recurring$333.0M69%
Cloud And Bureau Professional Services And Other$78.5M16%
Float$42.2M9%
Powerpay Recurring$19.7M4%
Other Recurring$8.2M2%

LIVN
LIVN

Other$169.4M47%
Neuromodulation Segment$119.7M33%
Cardiopulmonary Segment$71.8M20%

Related Comparisons